E-LIB Suche - Ergebnisse für: Vuitton, L

1

P927 Long-term outcomes of risankizumab in Crohn's disease:..:

Fumery, M ; Caron, B ; Hébuterne, X...
Journal of Crohn's and Colitis. 18 (2024) Supplement_1 - p. i1686-i1686 , 2024

2

P857 Effectiveness and safety of subcutaneous infliximab in..:

Andre, M ; Kirchgesner, J ; Laharie, D...
Journal of Crohn's and Colitis. 18 (2024) Supplement_1 - p. i1587-i1587 , 2024

Link: https://doi.org/10.1093/..

3

P386 Persistence of bowel urgency despite clinical remissio..:

Buisson, A ; Amiot, A ; Nachury, M...
Journal of Crohn's and Colitis. 18 (2024) Supplement_1 - p. i812-i812 , 2024

Link: https://doi.org/10.1093/..

4

P434 Incidence of chronic end-stage renal disease in patien..:

Prothe, C ; Boitel, A ; Martin, B...
Journal of Crohn's and Colitis. 18 (2024) Supplement_1 - p. i892-i892 , 2024

Link: https://doi.org/10.1093/..

5

P884 Patient satisfaction and experience after a switch to ..:

Bouguen, G ; Gossec, L ; Abitbol, V...
Journal of Crohn's and Colitis. 18 (2024) Supplement_1 - p. i1627-i1627 , 2024

Link: https://doi.org/10.1093/..

6

P322 Compared Efficacy of Second-Line Treatments for Ulcera..:

Calmejane, L ; Reenaers, C ; Amiot, A...
Journal of Crohn's and Colitis. 18 (2024) Supplement_1 - p. i707-i707 , 2024

Link: https://doi.org/10.1093/..

7

DOP65 Infliximab plus azathioprine and quick steroids disco..:

Amiot, A ; Seksik, P ; Meyer, A...
Journal of Crohn's and Colitis. 18 (2024) Supplement_1 - p. i191-i191 , 2024

Link: https://doi.org/10.1093/..

8

P960 Comparison of clinical outcomes by induction therapy r..:

Vuitton, L ; Mathieu, N ; Ye, B D...
Journal of Crohn's and Colitis. 18 (2024) Supplement_1 - p. i1743-i1744 , 2024

Link: https://doi.org/10.1093/..

9

P679 Anti-TNF de-escalation following a treat-to-target str..:

Vuitton, L ; Poullenot, F ; Bouhnik, Y...
Journal of Crohn's and Colitis. 18 (2024) Supplement_1 - p. i1290-i1290 , 2024

Link: https://doi.org/10.1093/..

10

P766 No difference in progression of disability 2 years aft..:

Vieujean, S ; Desseaux, K ; Laharie, D...
Journal of Crohn's and Colitis. 18 (2024) Supplement_1 - p. i1429-i1431 , 2024

Link: https://doi.org/10.1093/..

11

P1071 Patient preferences for adalimumab in inflammatory bo..:

Caron, B ; Seksik, P ; Buisson, A...
Journal of Crohn's and Colitis. 18 (2024) Supplement_1 - p. i1925-i1925 , 2024

Link: https://doi.org/10.1093/..

12

P903 Persistence, efficacy and tolerance of subcutaneous In..:

Mathieu, N ; Heluwaert, F ; Riviere, P...
Journal of Crohn's and Colitis. 18 (2024) Supplement_1 - p. i1655-i1655 , 2024

Link: https://doi.org/10.1093/..

13

Infliximab is an effective option in patients with ulcerati..:

Hupé, M. ; Streichenberger, A. ; Wils, P....
Digestive and Liver Disease. , 2024

Link: https://doi.org/10.1016/..

14

Association spondyloarthrite et maladies inflammatoires chr..:

Michel, J. ; Prati, C. ; Vuitton, L....
Revue du Rhumatisme. 90 (2023) - p. A196 , 2023

Link: https://doi.org/10.1016/..

15

DOP78 Does KONO-S anastomosis reduce recurrence in Crohn's ..:

Alibert, L ; Betton, L ; Falcoz, A...
Journal of Crohn's and Colitis. 17 (2023) Supplement_1 - p. i155-i155 , 2023

Link: https://doi.org/10.1093/..